Episodic Migraine
Episodic migraine is a type of headache disorder that causes recurrent, severe headaches often accompanied by nausea, vomiting, and sensitivity to light and sound.
Episodic Migraine: Xeomin Injections
We are studying Xeomin injections to see if they can help reduce the number of migraine days for people with episodic migraines. This trial compares Xeomin to a placebo to evaluate its effectiveness and safety.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have a diagnosis of migraine headaches for at least 12 months?
- Did your migraine headaches start before you turned 50 years old?
- In the last 3 months, have you had 6 to 14 migraine days each month?
- Are you currently taking more than one prescribed medication for migraine prevention?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medizinische Universitaet Innsbruck
Univ.-Klinik für Neurologie
Innsbruck, Austria
Landeskrankenanstalten-Betriebsgesellschaft Kabeg
Neurologie
Klagenfurt am Wörthersee, Austria
Pratia Brno s.r.o.
Brno, Czechia
Sponsor: Merz Therapeutics GmbH
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.